McKnight’s Senior Living April 24, 2024
(HealthDay News) — ChatGPT shows promise in polypharmacy management and deprescribing medications among the elderly, according to a study published online April 18 in the Journal of Medical Systems.
Arya Rao, from Harvard Medical School in Boston, and colleagues evaluated ChatGPT performance in polypharmacy management via its binary (yes/no) deprescribing decisions in standardized clinical vignettes.
The researchers found that in yes/no binary deprescribing decisions, ChatGPT universally recommended deprescribing medications regardless of activities of daily living (ADL) status in patients with no overlying cardiovascular disease (CVD) history. Among patients with CVD history, ChatGPT answers varied by technical replicate. The range for total number of medications deprescribed was 2.67 to 3.67 (out of seven) and...
Today's Sponsors
Today's Sponsor